Wealthcare Advisory Partners’s Zimmer Biomet ZBH Stock Holding History

Wealthcare Advisory Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-290	Closed	-$45K	–	1920
2021 Q1	$45K	Buy	+290	New	+$44.9K	﹤0.01%	912
2020 Q2	–	Sell	-171	Closed	-$17K	–	1401
2020 Q1	$17K	Hold	171	–	–	﹤0.01%	779
2019 Q4	$25K	Buy	171 +21	+14%	+$2.9K	﹤0.01%	711
2019 Q3	$20K	Sell	150 -6	-4%	-$775	﹤0.01%	758
2019 Q2	$18K	Hold	156	–	–	﹤0.01%	756
2019 Q1	$19K	Hold	156	–	–	﹤0.01%	681
2018 Q4	$16K	Buy	156 +151	+3,020%	+$17K	﹤0.01%	691
2018 Q3	$1K	Hold	5	–	–	﹤0.01%	1203
2018 Q2	$1K	Buy	+5	New	+$544	﹤0.01%	1196

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wealthcare Advisory Partners's ZBH Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Zimmer Biomet (ZBH) in Q2 2021, closing a stake of 290 shares — an estimated $45K sold.

Wealthcare Advisory Partners first reported a position in ZBH in Q2 2018 and held it in 9 quarters. The position peaked at $45K in Q1 2021. 1,018 funds tracked by Wall St. Rank hold ZBH as of Q2 2021.

Wealthcare Advisory Partners reported no remaining Zimmer Biomet position as of Q2 2021 after selling out during the quarter.
Wealthcare Advisory Partners sold 290 Zimmer Biomet shares in Q2 2021, an estimated $45K.
Wealthcare Advisory Partners first reported a position in Zimmer Biomet in Q2 2018 and held it in 9 quarters.
Wealthcare Advisory Partners's Zimmer Biomet position peaked at $45K in Q1 2021.
1,018 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.